Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells
Malvika Sharan on Twitter: "These 2 talks were public seminars at @NCBS_Bangalore. It's inspiring to see how Hari and Norman share their Scientific enthusiasm and contribute to each other's research in disorder
Facility - Sirano Dhe Paganon, PhD - Structural & Chemical Biology Center
PDF) Crystal Structure of the Pleckstrin Homology-Phosphotyrosine Binding (PH-PTB) Targeting Region of Insulin Receptor Substrate 1
Covalent Modifiers: March 2020
Sirano DHE-PAGANON | Dana-Farber Cancer Institute, Boston | DFCI | Department of Cancer Biology
Sirano DHE-PAGANON | Dana-Farber Cancer Institute, Boston | DFCI | Department of Cancer Biology
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities | Nature Communications
Gunning Group | Collaborators
Sirano Dhe-Paganon - Director and Principal Scientist, Longwood Center for Structural & Chemical Biology - Dana-Farber Cancer Institute | LinkedIn
Facility - Sirano Dhe Paganon, PhD - Structural & Chemical Biology Center
Leveraging Gas-Phase Fragmentation Pathways for Improved Identification and Selective Detection of Targets Modified by Covalent Probes,Analytical Chemistry - X-MOL
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism | Scientific Reports
Sirano Dhe Paganon, PhD - Structural & Chemical Biology Center - HOME
Sirano DHE-PAGANON | Dana-Farber Cancer Institute, Boston | DFCI | Department of Cancer Biology
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands - Remillard - 2017 - Angewandte Chemie International Edition - Wiley Online Library
New chemical technology boosts potency of targeted cancer therapy - Dana-Farber Cancer Institute | Boston, MA
PDF) FKBP Family Proteins: Immunophilins with Versatile Biological Functions
New chemical technology boosts potency of targeted cancer therapy - Dana-Farber Cancer Institute | Boston, MA
Phthalimide conjugation as a strategy for in vivo target protein degradation
Core Facilities - Dana-Farber Cancer Institute | Boston, MA
Facility - Sirano Dhe Paganon, PhD - Structural & Chemical Biology Center
Figure - Nature Structural & Molecular Biology
Sirano Dhe-Paganon's research works | Brandeis University, Waltham and other places
Facility - Sirano Dhe Paganon, PhD - Structural & Chemical Biology Center
